Aceso Life Science Group's (HKG:0474) subsidiary Hao Tian International Construction Investment Group (HKG:1341) is looking to raise up to HK$600 million in net proceeds via placement of up to 1,524,224,000 shares at HK$0.4 per share.
The number of shares to be placed represents 16.67% of the enlarged issued share capital of Hao Tian International, a Friday Hong Kong bourse filing said.
If all the shares are successfully placed, the company's shareholding in Hao Tian International will be diluted from 29.05% to 24.20% and Hao Tian International will cease to be a subsidiary of the company.
Hao Tian International plans to use the proceeds for its general working capital, development of its existing businesses, and for the investment and development of electric vehicles and charging station-related businesses.
The financial, property, and construction machinery company's shares closed nearly 3% lower on Monday.
Price (HKD): $0.08, Change: $-0.0020, Percent Change: -2.50%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。